Cargando…

Formulation and evaluation of transparent ibuprofen soft gelatin capsule

The compound ibuprofen, 2-(4-isobutylphenyl) propionic acid, has been known e.g. from Martindale, the Extra Pharmacopoeia, 28(th) edition, 1982, p.256, as a drug which had anti-inflammatory and analgesic properties. It is used for the treatment of rheumatoid arthritis or other inflammatory diseases...

Descripción completa

Detalles Bibliográficos
Autores principales: Lodha, A., Patel, A., Chaudhuri, J., Jadia, P., Joshi, T., Dalal, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467835/
https://www.ncbi.nlm.nih.gov/pubmed/23066224
http://dx.doi.org/10.4103/0975-7406.94154
_version_ 1782245880777146368
author Lodha, A.
Patel, A.
Chaudhuri, J.
Jadia, P.
Joshi, T.
Dalal, J.
author_facet Lodha, A.
Patel, A.
Chaudhuri, J.
Jadia, P.
Joshi, T.
Dalal, J.
author_sort Lodha, A.
collection PubMed
description The compound ibuprofen, 2-(4-isobutylphenyl) propionic acid, has been known e.g. from Martindale, the Extra Pharmacopoeia, 28(th) edition, 1982, p.256, as a drug which had anti-inflammatory and analgesic properties. It is used for the treatment of rheumatoid arthritis or other inflammatory diseases of joints, soft tissue rheumatism and gout. Ibuprofen, because of its analgesic properties, has been widely used as anodyne, e.g. against pain or discomfort associated with headache, toothache or menstruation. A medication suitable to combat acute pain is demanded to display its effects fast which action, in turn, is only achieved by a quick release and good bio-availability of the active-ingredient. It is for the commercial forms in particular that the conditions of preparation must be strictly observed, as minor alterations in production procedures such as mixing, pressure of compression and type of machine will affect the physical properties of the particles of he active ingredient and will deteriorate its bio-availability. It is an object of this presentation to provide a medicament that can be readily taken that contains an active amount of ibuprofen in a carrier, that is simple to prepare and that will quickly display a high activity.
format Online
Article
Text
id pubmed-3467835
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-34678352012-10-12 Formulation and evaluation of transparent ibuprofen soft gelatin capsule Lodha, A. Patel, A. Chaudhuri, J. Jadia, P. Joshi, T. Dalal, J. J Pharm Bioallied Sci Original/Brief The compound ibuprofen, 2-(4-isobutylphenyl) propionic acid, has been known e.g. from Martindale, the Extra Pharmacopoeia, 28(th) edition, 1982, p.256, as a drug which had anti-inflammatory and analgesic properties. It is used for the treatment of rheumatoid arthritis or other inflammatory diseases of joints, soft tissue rheumatism and gout. Ibuprofen, because of its analgesic properties, has been widely used as anodyne, e.g. against pain or discomfort associated with headache, toothache or menstruation. A medication suitable to combat acute pain is demanded to display its effects fast which action, in turn, is only achieved by a quick release and good bio-availability of the active-ingredient. It is for the commercial forms in particular that the conditions of preparation must be strictly observed, as minor alterations in production procedures such as mixing, pressure of compression and type of machine will affect the physical properties of the particles of he active ingredient and will deteriorate its bio-availability. It is an object of this presentation to provide a medicament that can be readily taken that contains an active amount of ibuprofen in a carrier, that is simple to prepare and that will quickly display a high activity. Medknow Publications & Media Pvt Ltd 2012-03 /pmc/articles/PMC3467835/ /pubmed/23066224 http://dx.doi.org/10.4103/0975-7406.94154 Text en Copyright: © Journal of Pharmacy and Bioallied Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original/Brief
Lodha, A.
Patel, A.
Chaudhuri, J.
Jadia, P.
Joshi, T.
Dalal, J.
Formulation and evaluation of transparent ibuprofen soft gelatin capsule
title Formulation and evaluation of transparent ibuprofen soft gelatin capsule
title_full Formulation and evaluation of transparent ibuprofen soft gelatin capsule
title_fullStr Formulation and evaluation of transparent ibuprofen soft gelatin capsule
title_full_unstemmed Formulation and evaluation of transparent ibuprofen soft gelatin capsule
title_short Formulation and evaluation of transparent ibuprofen soft gelatin capsule
title_sort formulation and evaluation of transparent ibuprofen soft gelatin capsule
topic Original/Brief
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467835/
https://www.ncbi.nlm.nih.gov/pubmed/23066224
http://dx.doi.org/10.4103/0975-7406.94154
work_keys_str_mv AT lodhaa formulationandevaluationoftransparentibuprofensoftgelatincapsule
AT patela formulationandevaluationoftransparentibuprofensoftgelatincapsule
AT chaudhurij formulationandevaluationoftransparentibuprofensoftgelatincapsule
AT jadiap formulationandevaluationoftransparentibuprofensoftgelatincapsule
AT joshit formulationandevaluationoftransparentibuprofensoftgelatincapsule
AT dalalj formulationandevaluationoftransparentibuprofensoftgelatincapsule